HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow TransplantationAmer M. Zeidan, Javier Bolaños‐Meade, Patrick M. Forde et al.|Biology of Blood and Marrow Transplantation|2013Cited by 113
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid LeukemiaAmer M. Zeidan, Eunice S. Wang|Clinical Cancer Research|2020Cited by 89
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Olivier Nibourel, Lin‐Pierre Zhao et al.|Journal of Clinical Oncology|2024Cited by 39
What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung CancerPatrick M. Forde, Julie R. Brahmer, Kim A. Reiss et al.|The Oncologist|2013Cited by 36
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Matteo Giovanni Della Porta, Elena Riva et al.|Journal of Clinical Oncology|2025Cited by 13